Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
about
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksEarly synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors.RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph diseaseATP as a multi-target danger signal in the brain.Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.Health benefits of methylxanthines in neurodegenerative diseases.How does adenosine control neuronal dysfunction and neurodegeneration?The neuroprotective effects of caffeine in neurodegenerative diseases.Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease.Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease.Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia.The role of microglia in the progression of glaucomatous neurodegeneration- a review.Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.
P2860
Q26740559-131DA41C-F3EA-499A-B068-1A27FBEF32AEQ27343149-510211FC-AC4A-401B-950F-06B04A5F5B6DQ34075342-25686620-7EF4-4D6C-A131-CFEA79403218Q35545478-05CC15ED-69FE-4CB5-B185-D1D3AEE3AD7EQ36043139-69033E2E-E1CD-4FD8-9466-C1B39145B186Q36898033-C40A537C-A93B-4F74-8CC7-CDBD32C2F407Q38167681-44548384-7050-46F7-BE25-8FFEBD32807FQ38714908-B6F156D3-39D7-4537-B928-9B5E602448C8Q38772021-8A5DB1A2-1A2B-4055-AEF2-5BE5F761135AQ38882782-51464B29-3864-49CB-842B-38EC8AF76C3BQ39186884-21C16FA2-011E-48CB-84F9-0D21B84198A1Q40358428-4A8FE940-8F22-458E-8665-A21F5E271AE9Q40683850-102948D3-48D9-4251-9318-04ED561FBA6DQ41195414-14EADCC0-3289-4177-ACFF-E28677447FB7Q46869076-CEBCE77C-C100-4D41-8AC9-D753117A1FC4Q48109313-726CC799-C80A-42CA-9482-44EDF40454CAQ49192854-C334F024-35C6-4408-9D73-2B425F9518E2Q51736038-C0CB4DCD-1C45-4AF9-AEC0-1D428019D41EQ52620604-0EB85E5A-0B9A-4703-9F8E-676105FA3FB4Q54572410-C7C2CD50-2AFC-4C10-9434-BF92BC96746BQ55266660-8F204CDB-0966-46A5-AB8F-F8F03E60D1F9
P2860
Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Caffeine and adenosine A(2A) r ...... del of Machado-Joseph disease.
@en
type
label
Caffeine and adenosine A(2A) r ...... del of Machado-Joseph disease.
@en
prefLabel
Caffeine and adenosine A(2A) r ...... del of Machado-Joseph disease.
@en
P2093
P2860
P356
P1433
P1476
Caffeine and adenosine A(2A) r ...... del of Machado-Joseph disease.
@en
P2093
Ana T Simões
Luís Pereira de Almeida
Nélio Gonçalves
P2860
P304
P356
10.1002/ANA.23866
P577
2013-04-26T00:00:00Z